Taiwan dermatological association recommendations for coronavirus disease of 2019 vaccination in patients treated with immunotherapeutics
This article aims to present current COVID-19 vaccination considerations for patients on immunotherapeutics for the management of immune-mediated dermatological diseases and summarize the recommendations relevant to clinical practice in Taiwan. These Taiwan Dermatological Association (TDA) recommend...
Saved in:
Main Authors: | Chih-Hung Lee (Author), Yu-Huei Huang (Author), Chia-Yu Chu (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Training and Retaining Physician‒Scientists in Dermatology in Taiwan
by: Yi-Shuan Sheen, et al.
Published: (2022) -
Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
by: Pei-Han Kao, et al.
Published: (2015) -
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
by: Kuldeep Dhama, et al.
Published: (2020) -
A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
by: Farah Marraha, et al.
Published: (2020) -
Human vaccines & immunotherapeutics: news
Published: (2021)